Market Tracker

09/21 8:00am ET

Altimmune Inc (NASDAQ:ALT)

2.53
Delayed Data
As of Sep 20
 +0.13 / +5.42%
Today’s Change
2.01
Today|||52-Week Range
14.70
-34.13%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close2.40
Today’s open2.45
Day’s range2.43 - 2.63
Volume71,922
Average volume (3 months)74,161
Market cap$37.4M
Dividend yield--
Data as of 09/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.84

Competitors

 Today’s
change
Today’s
% change
--Molecular Templates ...+0.12+1.92%
NVIVInVivo Therapeutics ...0.000.00%
HSGXHistogenics Corp-0.01-0.50%
AZRXAzurRx BioPharma Inc+0.45+10.34%
Data as of 09/20/2017

Financials

Last reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts